Dr. Peter A. Najjar highlights how artificial intelligence is accelerating cancer detection and improving patient care efficiency.

Dr. Peter A. Najjar, a surgeon and clinical innovation vice president at Johns Hopkins Health System, reports that artificial intelligence is significantly advancing cancer care by identifying patterns that previously required decades of physician experience. Specifically, AI models are helping researchers recognize signs of pancreatic cancer up to 16 months earlier than human readers, which provides patients with more treatment options. Beyond early detection, Dr. Peter A. Najjar notes that AI is accelerating drug development by allowing scientists to test molecules using computer models before moving to laboratory testing. The technology also improves the patient experience by using medical scribes to automate documentation, allowing doctors to focus more on their patients. While the technology offers immense promise, experts caution that it must be integrated thoughtfully. Dr. Peter A. Najjar emphasizes that more real-world evidence is still needed to measure the full impact of AI. Experts also stress that while AI can handle data and administrative tasks, it should serve as a tool to enhance, rather than replace, human empathy and clinical intuition.

Sources